Advertisements

Никс

Quick links to important sections

Никс

Selected form

Advertisements
Advertisements

Treatment option: Infection, Pediculosis

Medically reviewed

Marina Burgos

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Advertisements

Overview of Никс

What is Nix? Overview

Quick Facts Description
Active Ingredient Permethrin
Common Forms Cream, Lotion, Shampoo
Pharmacological Class Ectoparasiticide / Antiparasitic Agent
General Purpose Treatment of external parasitic infestations (lice, mites)
Origin Synthetic pyrethroid

Nix is a specialized medicinal product used for external (topical) use, clinically recognized for its efficacy against external human parasites. It is commonly available as an over-the-counter (OTC) treatment, positioning it as an accessible, non-prescription choice for managing common infestations.


Active Substance and Classification

The sole active ingredient in Nix is Permethrin, a powerful synthetic pyrethroid. Permethrin works by functioning as a neurotoxin to the target parasites, causing rapid nerve signal disruption and subsequent paralysis. It is recognized as a pediculicide used to treat lice infestations. Its synthetic nature provides enhanced stability compared to natural pyrethrins, which contributes to its sustained activity against the target organisms. Permethrin belongs to the ectoparasitic class, used against both lice and scabies mites.


Dosage Forms

As a single-agent product, Nix is available as a topical preparation in several dosage forms, including cream, lotion, and shampoo. The variety of forms ensures that the active ingredient can be applied effectively to different affected areas—from widespread skin coverage for mites (scabies) to targeted application in the hair for lice (pediculosis). This local application is key to the product's function.

Advertisements

What side effects are possible with Никс?

Possible Side Effects and Safety Information

The official safety profile for Permethrin (Nix) is characterized primarily by localized reactions at the application site, as detailed in regulatory documents such as FDA and EMA prescribing information. These adverse reactions are grouped by frequency and the affected physiological system.


Adverse Reaction Scope

Classification Examples of Reactions
Common Pruritus (itching), burning, stinging, erythema, tingling, and local skin dryness.
Rare Severe hypersensitivity reactions (e.g., anaphylaxis).

The majority of reported events are classified under Skin and Subcutaneous Tissue Disorders. These common reactions are often transient and may be exacerbated at the start of treatment. Furthermore, official labeling notes that persistent itching after treatment completion may occur and is often attributed to a reaction to non-viable parasites, distinguishing it from treatment failure.


Regulatory Safety Notes

The most serious systemic safety concern documented in regulatory texts relates to Immune System Disorders, specifically rare but severe Hypersensitivity Reactions. This risk forms the basis of the primary contraindication against use in individuals with a known allergy to Permethrin or other pyrethroids.

Regulatory safety information includes constraints for specific populations, notably the restriction or need for caution when administering the product to infants under two months of age. The product is strictly for external use only, with regulatory documents requiring avoidance of contact with the eyes and mucous membranes.

Advertisements

Overdose and Emergency Response

The official regulatory profile for Nix (Permethrin) overdose primarily addresses the systemic risks associated with accidental ingestion of the topical formulation, distinguishing this from the effects of excessive external application.

Documented Overdose Manifestations

Overuse confined to the skin may result in increased local irritation and erythema (redness) at the application site. Systemic overdose, which occurs upon accidental ingestion, has been associated with manifestations such as headache, dizziness, nausea, vomiting, weakness, and loss of appetite. Accidental ingestion carries the potential for severe Central Nervous System (CNS) effects, specifically seizures and loss of consciousness.

When to Seek Immediate Medical Help

For a suspected overdose resulting from accidental ingestion, official regulatory documents mandate that individuals seek immediate medical attention. A regional Poison Control Center should be contacted for guidance. Emergency services must be called if the individual who ingested the product has collapsed or is not breathing.

Supportive Management Measures

Treatment protocols described in regulatory sources emphasize general supportive measures. If the product is ingested, gastric lavage is indicated; however, the procedural instruction is to NOT induce vomiting. No specific antidote is known for Permethrin toxicity, and management is therefore focused on symptomatic support.

Advertisements

Therapeutic Uses of Никс

What Nix Treats: Main Uses and Benefits

The core therapeutic role of Nix (Permethrin) may be part of symptomatic management and addressing the parasitic cause in situations involving active external parasitic infestations. This medication is commonly used to address infestations caused by both mites and lice, and is considered relevant in ectoparasiticide therapy.

Therapeutic Scope

Nix is generally used for managing conditions characterized by periods of heightened symptoms, such as pediculosis (infestations of various lice types) and scabies (infestations of mites). This medication is commonly used and is often applied in scenarios involving school-aged children and the simultaneous treatment of close contacts.

“The application is used to support the patient during difficult episodes by easing the distress caused by intense itching and skin irritation.”

The medication helps address symptom clusters that may become intense or disruptive, particularly the intense pruritus (severe, persistent itching) and associated scalp irritation. By assisting in the control of organisms, it may assist with maintaining functional stability and contributes to easing the overall symptom load during symptomatic periods.


Quick Fact: Relief for Intense Pruritus

Therapeutic Focus Symptom Domain Patient Benefit
Addressing the Cause Active parasites and eggs Targeting the Source of Symptoms
Symptom Management Intense itching, irritation Easing the overall symptom load
Contextual Use Household, community settings Supports managing acute episodes

Regulatory References

  1. NIH MedlinePlus Drug Information
Advertisements

Eligibility and Restrictions for Use

The eligibility for using Никс (Permethrin) is strictly defined by regulatory authorities based on age and patient hypersensitivity, as detailed in official government labeling.

Contraindicated Populations

Use of this medicine is contraindicated in patients with a known hypersensitivity to the active substance, Permethrin, or to any related substances, including synthetic pyrethroids, pyrethrins, or chrysanthemums (Compositae plants) [DailyMed]. It is also prohibited for patients allergic to any inactive ingredients in the specific formulation.

Age-Related Eligibility and Restrictions

The 5% cream (scabicide) is safe and effective for pediatric patients two months of age and older. However, safety and effectiveness have not been established for infants less than two months of age, making this group non-eligible for treatment. For children between two and twenty-three months, treatment with the 5% cream is subject to close medical supervision due to limited clinical experience.

Physiological State Restrictions

Category Official Regulatory Status
Pregnancy Category B. Use should be considered only if clearly needed, as adequate human studies are lacking [DailyMed].
Lactation Not known if excreted in human milk. Consideration should be given to discontinuing nursing temporarily or withholding the drug [DailyMed].

For older adults, the label notes that while clinical studies did not involve a sufficient number of subjects aged 65 and over for a definitive statement on differential response, use is generally considered suitable. The medicine must not be applied to broken skin or mucous membranes.

Advertisements

What should I know about interactions with other medicines?

Interactions with other medicines and products

Interaction Scope

Category Official Regulatory Documentation
Medicinal product categories with documented interactions Topical Corticosteroids and other Topical Medications
Specific interacting medicines (if explicitly listed) None explicitly listed as systemic interacting medicines.
Mechanistic basis of interactions Pharmacodynamic interaction (interference with treatment efficacy). Negligible Pharmacokinetic Interaction Risk (due to minimal systemic absorption).
Timing-based interaction rules Discontinuation is required for certain topical medications prior to application.
Population-specific interaction notes None documented.
Interaction-related restrictions Restriction on concurrent use of certain topical agents (specifically corticosteroids).

Resulting Interaction Structure

Official regulatory documentation establishes that the interaction profile for topical Permethrin (Nix) is characterized by a minimal systemic interaction risk. Due to the negligible systemic exposure of the active ingredient, no significant systemic drug–drug interactions are known or expected, and co-administration with systemic medicinal products, food, alcohol, or herbal products is not restricted in regulatory labeling.

The primary constraint described is a topical pharmacodynamic restriction. Other topical medications, particularly topical corticosteroids, should be discontinued before the application of Nix. This procedural constraint is intended to prevent the worsening or masking of the underlying ectoparasitic condition, which is a documented interaction-related concern.

Advertisements

Mechanism of Action

How Никс Works


The mechanism of action is defined by the direct modulation of Voltage-Gated Sodium Channels ( VGSCs) found in the nervous system of the target ectoparasites. Permethrin molecules function by binding to these channels, which severely delays their normal inactivation and closure. This mechanical interference initiates a neurotoxic cascade by causing a sustained, uncontrolled influx of sodium ions ( Na^+) into the parasite's nerve cell.

The massive sodium influx results in prolonged depolarization and nervous system hyperexcitability, ultimately leading to functional failure. This critical neurological overload rapidly translates into functional motor and respiratory paralysis of the parasite, which is the primary physiological consequence of the mechanism.

The effectiveness of this neurotoxic action is subject to certain biological limitations, including Target Site Insensitivity ( kdr mutations) that reduce drug binding affinity, and the parasite's own metabolic detoxification pathways that can enzymatically break down the active molecule.

Advertisements

Dosage and Administration Information

Instruction Map: How to use Никс — Official Administration Guidelines

This section outlines the official, label-based usage protocols for Permethrin (Никс).

Administration Scope Detail
Route of administration Topical (External application only).
Dosing schedule (Adults) 5% Cream (Scabies): Applied from the neck to the soles of the feet.
1% Lotion (Lice): Saturates hair and scalp.
Preparation requirements Head Lice: Apply to shampooed, towel-dried (damp) hair; conditioner must be avoided prior to application.
Age-group administration rules The 5% cream is sanctioned for use in children 2 months of age and older. Application for infants and older adults must include the scalp, hairline, and face.
Special procedural conditions The product must be left on for a specific dwell time before removal: 8 to 14 hours for the 5% cream; 10 minutes for the 1% lotion.

Resulting Procedural Structure

Official step sequence:

  • Apply the designated topical form (5% cream or 1% lotion) to the specified area (entire body for scabies; saturated hair/scalp for lice).
  • Allow the product to remain on the body/hair for the exact labeled duration (10 minutes or 8–14 hours), but no longer.
  • Remove the product by showering or rinsing with water.
  • Retreatment is administered 7 to 14 days later only if new or persistent live parasites are positively identified.

Connection to the Overall Use Protocol

These official instructions establish the use of Permethrin as an intermittent, short-course treatment defined by form and time constraints. The regimen mandates a single, exhaustive application followed by a required wash-off period, with a second dose reserved solely for confirmed treatment failure rather than routine daily or maintenance use.

Advertisements

Recent Clinical Evidence

Research evidence / Overview of studies for Permethrin (Nix)

Evidence for use in Active Scabies Infestation

Research has examined the use of permethrin 5% cream for mite infestations, a condition where symptoms may vary in intensity. The research base primarily involves Randomized Controlled Trials (RCTs) and systematic reviews, which was studied for short-term symptom patterns in affected populations.

Studies explored outcomes related to physical discomfort, specifically measuring the clinical cure rate (monitoring for absence of live mites) and the resolution of skin lesions over defined time intervals. Research also monitored the persistence and evolution of pruritus (itching). Findings describe patterns observed in the studies related to outcomes monitored following one or two applications.

Findings were mixed across regions because studies have reported measurements of reduced mite sensitivity in certain geographic areas. Research does not determine whether an individual will respond similarly; findings describe group patterns, not personal outcomes.


Evidence for use in Pediculosis (Lice Infestations)

Research examined the use of permethrin 1% formulations for head and pubic lice infestations using Randomized Controlled Trials (RCTs). Studies monitored outcomes reflecting the parasitic load, such as the eradication rate (absence of live lice) and the outcomes linked to the eggs (ovicidal activity).

Research highlights changes measured during the study period, but the consistency of these findings sometimes varied. This variability was associated with documented resistance in lice populations. Data show patterns related to lice resistance, which affects outcomes, and research is ongoing.


Long-term Outcomes and Durability of Effect

Research has explored the patterns of recurrence monitored following short-term studies, but long-term effects are not fully established. Most clinical trials focus on short-term changes, monitoring outcomes for a few weeks to ensure the initial treatment was assessed. Studies examining patient-reported experiences related to stability of the condition over extended periods are less common.


Evidence in Special Study Populations

Permethrin was evaluated in studies including pediatric populations, particularly children aged 2 months and older, across many of the RCTs conducted for both scabies and pediculosis. However, data for certain groups remain insufficient, such as limited information for long-term outcomes in older adults.

Key Studies & References Permethrin Topical: MedlinePlus Drug Information

Advertisements

Frequently Asked Questions (FAQ)

Common questions about Никс (FAQ)

Q: Is Никс available over the counter?

A: The official regulatory status varies based on the strength of the product. The 1% permethrin formulation, which is commonly used for head lice, is typically available over-the-counter (OTC). However, the 5% permethrin cream, which is prescribed for scabies, is generally available by prescription only.

Q: Are there different strengths or forms of Никс available?

A: According to official product information, Permethrin, the active ingredient in Никс, is prepared as a topical product in different strengths and forms. These typically include a 1% formulation (lotion or shampoo) and a 5% cream. The variety of forms available is designed to address different external parasitic infestations.

Q: Is it okay to use Никс if I am taking vitamins or supplements?

A: Official regulatory documents indicate that the active ingredient in Никс has minimal absorption into the bloodstream. For this reason, significant systemic (body-wide) drug-drug interactions are not known or expected. Co-administration with systemic medications, including vitamins or supplements, is not addressed as a restriction in the official labeling.

Q: Does Никс interact with common pain relievers like ibuprofen?

A: Regulatory information establishes that the interaction profile for this topical product carries a minimal systemic risk. Due to the negligible amount of the active ingredient that reaches the bloodstream, significant systemic interactions with common pain relievers like ibuprofen are not known or expected.

Q: What if I'm pregnant or breastfeeding, is there information about using Никс?

A: The product is classified as Pregnancy Category B. The official documentation states that use should be considered only if clearly needed. For those who are breastfeeding, it is not known whether the substance is passed into human milk, and official guidance suggests considering temporarily stopping nursing or withholding the medication.

Q: Can I crush or open the Никс form if I have trouble swallowing?

A: The product is strictly intended for external (topical) use and is not designed to be taken by mouth. Regulatory documents explicitly instruct that the product must be kept away from the eyes and mucous membranes.

Q: How does Никс compare to non-prescription remedies for the same problem?

A: The active ingredient in Никс is Permethrin, which is chemically classified as a synthetic pyrethroid antiparasitic. Official research has examined the mechanism of action of this agent against target parasites. This is a specific pharmacological classification.

Q: Does Никс contain any common allergens like gluten or lactose?

A: Contraindications for use are based on a known allergy to the active ingredient, Permethrin, related substances, or any inactive ingredients (known as excipients) within the specific formulation. Information regarding the presence of specific food allergens like gluten or lactose is not uniformly published in the main drug label sections.

Q: What should I do if I think I missed using a dose of Никс?

A: The administration guidelines describe a single, short-course application with a precise removal time. The regimen is defined by a single, short-course application. Official instructions state that a second application is only recommended 7 to 14 days later if new, persistent live parasites are positively identified.

Q: Are there any known drug classes that interact with Никс?

A: Regulatory documentation lists only topical medications, specifically including topical corticosteroids, as having documented interactions with Никс. No systemic drug classes are listed as having significant known or expected interactions due to the product’s minimal systemic absorption.

Q: Why is Никс sometimes called [alternate/brand name]?

A: Никс is a brand name for the active pharmaceutical ingredient Permethrin. Since the chemical name is Permethrin, the product may be referred to by its generic name or by other brand names used for similar permethrin-containing products marketed by other companies.

Q: What is the typical experience users have when first starting Никс?

A: In clinical trials, the majority of reported events were characterized as localized and transient reactions at the application site. These may commonly include sensations such as burning, stinging, itching, or tingling. These effects were sometimes associated with the severity of the initial infestation.

Q: Can certain foods or drinks affect how Никс works?

A: According to the official product monograph, no interactions between Permethrin and food have been established. This is consistent with the product’s topical route of administration and minimal systemic absorption.

Q: Is it possible to develop a tolerance to Никс?

A: Official research has documented variability in effectiveness, which has been associated with the development of resistance in the parasite populations over time. Regulatory information does not address the development of tolerance in the human host.

Q: Why is alcohol use often mentioned in warnings for medications like Никс?

A: While many systemic medications require alcohol restrictions, official documentation for Никс states that co-administration with alcohol is not restricted. This is because the drug is topical and has negligible systemic exposure, so typical alcohol warnings related to internal bodily systems are not relevant here.

Q: Is it true that Никс is derived from a natural source?

A: The active ingredient, Permethrin, is classified as a synthetic pyrethroid. While it is chemically related to natural compounds called pyrethrins (which are found in certain types of chrysanthemum flowers), Permethrin itself is manufactured synthetically.

Q: Can older adults (seniors) use Никс?

A: Use in older adults is generally considered suitable. For the 5% cream, certain regulatory documents suggest that the application procedure should specifically include the scalp, hairline, and face, in addition to the rest of the body.

Q: Is it normal to feel a tingling sensation after using Никс?

A: Yes, a tingling sensation at the application site is reported in the list of common adverse reactions in the official regulatory labeling. This suggests it is a recognized and expected reaction following the application of the product.

Q: What kind of information is available about Никс in clinical trials?

A: Clinical trials often focus on specific, short-term outcomes such as the clinical cure rate, which monitors the absence of live parasites. These studies track results at defined time points, often for a few weeks post-treatment, to assess the initial effectiveness.

Q: Is Никс generally considered to be a short-term or long-term product?

A: The official administration instructions describe a single, exhaustive application followed by a wash-off period. This procedural structure defines the product as an intermittent, short-course treatment.

Q: Are there common signs that Никс is working as intended?

A: Official research monitors outcomes such as the clinical cure rate (meaning the absence of live mites or lice) and the eventual resolution of skin lesions. It is noted that itching may persist temporarily after treatment due to the reaction to non-viable parasites, which is not an indication of treatment failure.

Q: What are the main risks outlined in the official documentation for Никс?

A: The primary risks documented include the potential for rare, severe hypersensitivity reactions to the ingredients, the need to avoid contact with sensitive areas like eyes and mucous membranes, and restrictions on use in infants under two months of age. Additionally, the product is highly toxic to aquatic life, requiring adherence to specific disposal protocols.

Q: Why does the packaging for Никс mention specific age restrictions?

A: The official age restriction exists for infants under two months of age because the safety and effectiveness of the product have not been fully established or studied in this particular patient population.

Q: Is there any public research on the long-term effects of Никс?

A: Research has explored patterns of recurrence that were monitored following short-term studies. However, the official documentation indicates that long-term effects of the product are not fully established, as most clinical trials focus on short-term outcomes.

Q: Why is it important to check the expiration date on Никс?

A: Official storage instructions require that any expired product be disposed of properly. Checking the expiration date is standard practice for all medicines to ensure the product maintains its intended potency and stability up until that date.

Q: Is there a generic version of Никс available?

A: Yes, the active ingredient in Никс is Permethrin. Permethrin is widely available as a generic product, in addition to being sold under various brand names, including Никс.

Q: Does the way Никс is applied or taken influence its effectiveness?

A: Official dosage and administration instructions specify a mandatory, precise procedural structure for application. These instructions include required preparation (such as applying to damp hair) and a specific dwell time, which indicates these steps are important for the product to function as intended.

Advertisements

How should Никс be stored and disposed of?

How to Store and Dispose of Nix (Permethrin)

Official Storage Requirements

Regulatory labeling specifies that Nix must be stored at Controlled Room Temperature, which ranges from 20 C to 25 C (68 F to 77 F). The product must be kept from freezing and protected from excess heat and moisture. To ensure child safety, the medication must be stored out of reach of children and kept in the original container, tightly closed.

Disposal and Environmental Protection

Unused or expired product must be disposed of in accordance with local, state, and federal regulations. Due to the active ingredient's extreme toxicity to aquatic organisms, it is strictly forbidden to dispose of the product by pouring it down any drain or toilet. Consult the local solid waste agency for instructions on discarding partially used containers. Empty containers should not be reused.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Никс found in:

A-Z Index: